BREAST LOBULAR CARCINOMA IN SITU
Clinical trials for BREAST LOBULAR CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new BREAST LOBULAR CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for BREAST LOBULAR CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug tested to fight back against stubborn breast cancer
Disease control TerminatedThis study tested if a drug called abemaciclib could help control a hard-to-treat type of breast cancer that did not fully respond to standard chemotherapy. It involved 26 women whose cancer could still be surgically removed. The goal was to see if taking the drug for a short per…
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
New gel offers hope for breast cancer prevention with fewer side effects
Prevention TerminatedThis study aimed to find a better way to prevent breast cancer in women at high risk. It compared a standard oral pill (tamoxifen) to a new topical gel applied to the breast, hoping the gel would work just as well but cause fewer body-wide side effects. Researchers planned to che…
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Prevention
Last updated Apr 02, 2026 14:57 UTC